Calevia’s Management


Gary Economo

Chief Executive Officer

Mr. Economo has a distinguished business leadership career, serving as CEO for a number of public and private high technology companies during the last 20 years. A former President and CEO of Dynasty Components Inc., Mr. Economo enjoys a long history of marketing and sales for high-tech applications. He is a founding partner at Grafoid Inc. — a privately held Canadian corporation investing in graphene applications and economically scalable production processes for the MesoGraf™ suite of products — where he serves as Chief Executive Officer. He is also CEO and a Director at Focus Graphite Inc., a TSX Venture-listed graphite mining and graphene development company.

Over the span of his business career, Mr. Economo provided strategic consulting and representation services to technology companies in North America and Asia. In particular, he has a track record of success and expertise in building shareholder value when tasked with bringing discovery companies to market. Born in Greece and raised in Montreal, Mr. Economo is tri-lingual and lives with his family in Ottawa.

 




Gordon Chiu, B.Sci., MSci, f-MSTP, ND

Co-Manager, Senior Advisor to Calevia

Described as an “execution-driven businessman,” Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. He is co-founder at Grafoid Inc., where he is currently President and Chief Technology Officer. Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and its subsidiaries, as well as the development of graphene applications with Grafoid’s joint venture application development partners. He is also Chief Scientist at Focus Graphite Inc. Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.

Dr. Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health’s Medical Scientist Training Program (MSTP) at the Mount Sinai School of Medicine. Dr. Chiu jointly combined his cumulative training with a Doctor of Naturopathic Medicine (ND) degree from the University of Bridgeport.